SE361044B - - Google Patents
Info
- Publication number
- SE361044B SE361044B SE05432/70A SE543270A SE361044B SE 361044 B SE361044 B SE 361044B SE 05432/70 A SE05432/70 A SE 05432/70A SE 543270 A SE543270 A SE 543270A SE 361044 B SE361044 B SE 361044B
- Authority
- SE
- Sweden
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Clamps And Clips (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81805769A | 1969-04-21 | 1969-04-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE361044B true SE361044B (de) | 1973-10-15 |
Family
ID=25224552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE05432/70A SE361044B (de) | 1969-04-21 | 1970-04-20 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3502663A (de) |
| AT (1) | AT296503B (de) |
| BR (1) | BR6914873D0 (de) |
| CH (1) | CH529789A (de) |
| CS (1) | CS166256B2 (de) |
| ES (1) | ES378831A1 (de) |
| NO (1) | NO135067C (de) |
| PL (1) | PL80656B1 (de) |
| SE (1) | SE361044B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL149810B (nl) * | 1969-04-21 | 1976-06-15 | Lilly Co Eli | Werkwijze ter bereiding van een farmaceutisch preparaat door kristallijn cefalexine in een voor therapeutische toediening geschikte vorm te brengen, gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van voor bovengenoemde toepassing geschikt cefalexine. |
| GB1317159A (en) * | 1969-09-26 | 1973-05-16 | Glaxo Lab Ltd | Manufacture of cephalosporin compounds |
| IT1126544B (it) * | 1979-12-07 | 1986-05-21 | Dobfar Spa | Procedimento per la preparazione di derivati dell'acido 7-amino-desacetossi cefalosporanico |
| JPS60231683A (ja) * | 1984-05-02 | 1985-11-18 | Teijin Ltd | セフアロスポリン誘導体その製造法及びそれを有効成分とする抗菌剤 |
| US5278157A (en) * | 1989-07-10 | 1994-01-11 | Gema, S.A. | Stable cephradine hydrate |
| US5399686A (en) * | 1993-06-04 | 1995-03-21 | Eli Lilly And Company | Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate |
| US5352782A (en) * | 1993-06-04 | 1994-10-04 | Eli Lilly And Company | Process for preparing crystalline β-lactam monohydrate |
| US5374719A (en) * | 1993-06-04 | 1994-12-20 | Eli Lilly And Company | Process for converting loracarbef dihydrate to loracarbef monohydrate |
| US5580977A (en) * | 1995-03-01 | 1996-12-03 | Eli Lilly And Company | Process for preparing loracarbef monohydrate |
-
1969
- 1969-04-21 US US818057A patent/US3502663A/en not_active Expired - Lifetime
- 1969-12-08 BR BR214873/69A patent/BR6914873D0/pt unknown
-
1970
- 1970-04-10 CH CH537370A patent/CH529789A/de not_active IP Right Cessation
- 1970-04-15 AT AT343570A patent/AT296503B/de not_active IP Right Cessation
- 1970-04-20 NO NO1493/70A patent/NO135067C/no unknown
- 1970-04-20 PL PL1970140132A patent/PL80656B1/pl unknown
- 1970-04-20 SE SE05432/70A patent/SE361044B/xx unknown
- 1970-04-20 ES ES378831A patent/ES378831A1/es not_active Expired
- 1970-04-21 CS CS2693A patent/CS166256B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL80656B1 (en) | 1975-08-30 |
| NO135067C (de) | 1977-02-02 |
| US3502663A (en) | 1970-03-24 |
| CH529789A (de) | 1972-10-31 |
| AT296503B (de) | 1972-02-25 |
| BR6914873D0 (pt) | 1973-03-08 |
| ES378831A1 (es) | 1973-01-16 |
| NO135067B (de) | 1976-10-25 |
| CS166256B2 (de) | 1976-02-27 |